Inhibition of ferroptosis improves developmental competence of vitrified–warmed oocytes
-
By
-
Tianli Huang
-
Yutong Huang
-
Xuanqi Liu
-
Jiaying Mo
-
Yining Cao
-
Yishang Yan
-
Jun Ren
-
Xinyuan Li
-
Jianzhong Sheng
-
Hong Zhu
-
Hefeng Huang
-
June 15, 2026
-
Clinical Scorecard: Blocking ferroptosis enhances the developmental potential of vitrified and warmed oocytes
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Ferroptosis-related alterations, oxidative stress, mitochondrial dysfunction |
| Target Population | |
| Care Setting | |
Key Highlights
- Vitrification–warming impairs oocyte quality and embryonic development.
- Ferroptosis is activated post-vitrification–warming, leading to oxidative stress.
- Inhibition of ferroptosis with Fer-1 or GSH-MEE improves oocyte quality.
Guideline-Based Recommendations
Diagnosis
- Assessment of oocyte quality post-vitrification and warming.
Management
Monitoring & Follow-up
- Evaluation of oxidative stress markers and mitochondrial function in oocytes.
Risks
- Increased reactive oxygen species production and organelle dysfunction post-vitrification.
Patient & Prescribing Data
Mouse model used for experimental validation.
Ferrostatin-1 and glutathione monoethyl ester improve outcomes after cryopreservation.
Clinical Best Practices
Related Resources & Content
